| Title : Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__ |
| Author(s) : Yokokawa A , Kaneko S , Endo S , Minowa Y , Ayukawa H , Hirano R , Nagashima F , Naruge D , Okano N , Kobayashi T , Kawai K , Furuse J , Furuta T , Shibasaki H |
| Ref : Eur J Drug Metab Pharmacokinet , : , 2021 |
| Abstract : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__ |
| ESTHER : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__ |
| PubMedSearch : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__ |
| PubMedID: 33619631 |
Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H (2021)
Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms
Eur J Drug Metab Pharmacokinet
:
Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H (2021)
Eur J Drug Metab Pharmacokinet
: